Mentover
Board
1 director, last change in 2023VH Pharma BV
Director (not named in the articles), permanent representative Elien Van Hove
since 01-09-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 15-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 04-04-2022
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- VH Pharma
- Director (not named in the articles), from 03-01-2017 to date
- Elien Van Hove
- Director, from 03-01-2017 to 02-03-2023
- Director, formerly manager, until 04-04-2022
- Stephanie Verluyten
- Director, from 03-01-2017 to 02-03-2023
- Director, formerly manager, until 04-04-2022
Control
Parent
Equity €236,430
Profit €38,454 in 2025 (profit €154,962 in 2024)
Source: accounts VH Pharma 2025
100%
This company
Mentover
Equity €45,044
Profit €53,864 in 2025
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- VH Pharma
Source: lists of holdings in the owners' accounts
Articles of association
deed of 04-04-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 19:00
Capital transactions
Capital over time
- 04-04-2022 Converted to unavailable equity
- 04-04-2022 Converted to available equity